ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 121 filers reported holding ANI PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 3.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,028 | -63.1% | 56,244 | -72.7% | 1.04% | -62.9% |
| Q1 2023 | $8,195 | -43.6% | 206,328 | -42.9% | 2.80% | -45.0% |
| Q4 2022 | $14,541 | -99.9% | 361,447 | -1.6% | 5.09% | +6.5% |
| Q3 2022 | $11,806,000 | +8.2% | 367,326 | -0.1% | 4.78% | +17.2% |
| Q2 2022 | $10,911,000 | +18.4% | 367,754 | +12.1% | 4.08% | +25.8% |
| Q1 2022 | $9,218,000 | -39.1% | 327,929 | -0.2% | 3.24% | -31.4% |
| Q4 2021 | $15,137,000 | +38.2% | 328,494 | -1.6% | 4.72% | +30.0% |
| Q3 2021 | $10,952,000 | +30.7% | 333,686 | +39.6% | 3.63% | +23.8% |
| Q2 2021 | $8,380,000 | +5.4% | 239,101 | +8.7% | 2.93% | -1.2% |
| Q1 2021 | $7,949,000 | +70.2% | 219,962 | +36.8% | 2.97% | +58.0% |
| Q4 2020 | $4,670,000 | – | 160,796 | – | 1.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
| Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
| Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
| Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
| 1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
| THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
| Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
| Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |